Eye drops could replace needles for Diabetes-Related vision loss
NCT ID NCT06172257
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a steroid eye drop called OCS 01 can improve vision in people with diabetic macular edema, a common cause of vision loss in diabetes. Over 400 participants used the drops several times daily for a year. The goal was to see if this non-invasive treatment could match or beat current injection therapies.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Dexamethasone eye drops (OCS 01)
- What this could lead to
- If it works, this could offer a simple eye drop alternative to eye injections for controlling diabetic macular edema and improving vision.
- What could go wrong
- This is a completed Phase 3 trial, but results are not yet public. Eye drops may be less effective than injections, and side effects like increased eye pressure or cataracts are possible with steroids.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
401 people
The number who actually took part.
- Started
-
Mar 2024
- Finished
-
Apr 2026
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 85 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria (selection): 1. Have a signed informed consent form before any study-specific procedures are performed. 2. Have DME with presence of intraretinal and/or subretinal fluid in the study eye, with CST of ≥310 µm by SD-OCT at screening (Visit 1) (as assessed by an independent reading center). 3. Have a documented diagnosis of Type 1 or Type 2 diabetes mellitus prior to screening (Visit 1). Exclusion Criteria (selection): 1. Have macular edema considered to be because of a cause other than DME. 2. Have a decrease in BCVA because of causes other than DME. 3. Have a known history of significant macular ischemia which would prevent gain in visual acuity in the study eye.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diabetic macular edema are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Advanced Research
Coral Springs, Florida, 33067, United States
-
Agrawal Hospital
Jaipur, Rajasthan, 302004, India
-
Associated Retina Consultants
Gilbert, Arizona, 85297, United States
-
Associated Retina Consultants
Phoenix, Arizona, 85020, United States
-
Austin Retina Associates
Round Rock, Texas, 78681, United States
-
Blue Ocean Clinical Research
Clearwater, Florida, 33761, United States
-
Buenos Aires Macula (BAM) Clinical Research
CABA, Buenos Aires, C1061AAE, Argentina
-
California Retina Consultants
Bakersfield, California, 93309, United States
-
California Retina Consultants
Santa Barbara, California, 93103, United States
-
Centro De Ojos Loria Srl
CABA, Buenos Aires, 1663, Argentina
-
Centro Privado de Ojos
CABA, Buenos Aires, 1663, Argentina
-
Centro Privado de Ojos Romagosa
Córdoba, Córdoba Province, 5000, Argentina
-
Centro de la Vision Dr. Kolton
Salta, Salta Province, A4400, Argentina
-
Charles Centro Oftalmológico
Ciudad Autónoma de Buenos Aires, Buenos Aires, C1008, Argentina
-
Charles Retina Institute
Germantown, Tennessee, 38138, United States
-
Cumberland Valley Retina Consultants
Hagerstown, Maryland, 21740, United States
-
East Coast Institute for Research
Jacksonville, Florida, 32256, United States
-
Emanuelli Research & Development Center
Arecibo, 00612, Puerto Rico
-
Erie Retina Research
Erie, Pennsylvania, 16507, United States
-
Eye Care Center of Northern Colorado
Longmont, Colorado, 80503, United States
-
Fundacion Zambrano
Buenos Aires, Buenos Aires, 1023, Argentina
-
GSVM Medical College
Kanpur, Uttar Pradesh, 208005, India
-
Georgia Retina
Peachtree City, Georgia, 30269, United States
-
Grupo Laser Vision
Rosario, Santa Fe Province, S2000 PRB, Argentina
-
Houston Eye Associates, North Loop
Houston, Texas, 77025, United States
-
Illinois Retina Associates
Oak Park, Illinois, 60304, United States
-
Instituto de Microcirugía Ocular Córdoba (IMOC)
Córdoba, Córdoba Province, X5016KEH, Argentina
-
Island Retina
Shirley, New York, 11967, United States
-
Lotus Eye Hospital and Institute
Coimbatore, Tamil Nadu, 641014, India
-
Macula Retina Vitreous Center
Torrance, California, 90503, United States
-
Marietta Eye Clinic
Marietta, Georgia, 30060, United States
-
Medical Center Ophthalmology Associates
San Antonio, Texas, 78240, United States
-
Mid Atlantic Retina Specialists
Hagerstown, Maryland, 21740, United States
-
Mississippi Retina Associates
Jackson, Mississippi, 90033, United States
-
Narayana Nethralaya
Bangalore, Karnataka, 560010, India
-
Oftalmologìa Global
Rosario, Santa Fe Province, S2000, Argentina
-
Oftalmos - Instituto Oftalmológico de Alta Complejidad
Buenos Aires, Buenos Aires, C1120 AAN, Argentina
-
Oftar Mendoza - Centro Privado de Oftalmología en Mendoza Capital
Mendoza, Mendoza Province, M5500, Argentina
-
Ophthalmic Consultants of Boston
Boston, Massachusetts, 02114, United States
-
Organizacion Medica De Investigacion
CABA, Buenos Aires, C1015, Argentina
-
Palmetto Retina Center
West Columbia, South Carolina, 29169, United States
-
Piedmont Eye Center
Lynchburg, Virginia, 24502, United States
-
Retina Associates of Southern California
Huntington Beach, California, 92647, United States
-
Retina Consultants of Southwest Florida
Naples, Florida, 33912, United States
-
Retina Consultants of Texas
Bellaire, Texas, 77401, United States
-
Retina Group of Florida
Fort Lauderdale, Florida, 33308, United States
-
Retina Specialists of Colorado
Denver, Colorado, 80210, United States
-
Retinal Consultants Medical Group
Sacramento, California, 95841, United States
-
Retinal Consultants Medical Group, Inc
Sacramento, California, 95825, United States
-
Retinal Consultants of Arizona - Phoenix North
Phoenix, Arizona, 85053, United States
-
Rising Retina Clinic
Ahmedabad, Gujarat, 380015, India
-
San Antonio Eye Center - Downtown Clinic
San Antonio, Texas, 78215, United States
-
Sibia Eye Institute
Boynton Beach, Florida, 11195, United States
-
Sierra Eye Associates
Reno, Nevada, 89502, United States
-
St. Theresa's Hospital
Hyderabad, Telangana, 500038, India
-
Stanford Byers Eye Institute
Palo Alto, California, 94303, United States
-
Star Retina
Burleson, Texas, 76028, United States
-
Tennessee Retina
Nashville, Tennessee, 37203, United States
-
Tyler Retina Consultants
Tyler, Texas, 75703, United States
-
Vision Research Solutions in Philadelphia
Philadelphia, Pennsylvania, 19141, United States
-
VitreoRetinal Consultants of NY
Hauppauge, New York, 11788, United States
-
Vitreoretinal Consultants of NY
Westbury, New York, 11590, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- The 20-Minute squeeze: how eye injections push pressure up
- Could years of eye injections weigh down the upper eyelid?
- Eye implant takes aim at diabetic macular edema
- Can a single gene therapy injection ease diabetic macular edema?
- Can a new eye injection preserve vision in south asians with diabetes?
- Could a biosimilar eye injection offer a new way to treat diabetic macular edema?